These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32961130)

  • 1. NURA: A curated dataset of nuclear receptor modulators.
    Valsecchi C; Grisoni F; Motta S; Bonati L; Ballabio D
    Toxicol Appl Pharmacol; 2020 Nov; 407():115244. PubMed ID: 32961130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the binding of small molecules to nuclear receptors using machine learning.
    Ramaprasad ASE; Smith MT; McCoy D; Hubbard AE; La Merrill MA; Durkin KA
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35383362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.
    Réau M; Lagarde N; Zagury JF; Montes M
    J Med Chem; 2019 Mar; 62(6):2894-2904. PubMed ID: 30354114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and Chemogenomics.
    Isigkeit L; Chaikuad A; Merk D
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.
    Matsuzaka Y; Uesawa Y
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
    Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
    J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive exploration of chemical space with Scaffold Hunter.
    Wetzel S; Klein K; Renner S; Rauh D; Oprea TI; Mutzel P; Waldmann H
    Nat Chem Biol; 2009 Aug; 5(8):581-3. PubMed ID: 19561620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
    Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
    J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity-guided mapping and navigation of chemical space.
    Renner S; van Otterlo WA; Dominguez Seoane M; Möcklinghoff S; Hofmann B; Wetzel S; Schuffenhauer A; Ertl P; Oprea TI; Steinhilber D; Brunsveld L; Rauh D; Waldmann H
    Nat Chem Biol; 2009 Aug; 5(8):585-92. PubMed ID: 19561619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Chemical Environment to Support 21st-Century Toxicology.
    Bell SM; Phillips J; Sedykh A; Tandon A; Sprankle C; Morefield SQ; Shapiro A; Allen D; Shah R; Maull EA; Casey WM; Kleinstreuer NC
    Environ Health Perspect; 2017 May; 125(5):054501. PubMed ID: 28557712
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of toxicological information in drug design.
    Matthews EJ; Benz RD; Contrera JF
    J Mol Graph Model; 2000 Dec; 18(6):605-15. PubMed ID: 11155316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity, assay and target data curation and quality in the ChEMBL database.
    Papadatos G; Gaulton A; Hersey A; Overington JP
    J Comput Aided Mol Des; 2015 Sep; 29(9):885-96. PubMed ID: 26201396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illuminating the druggable genome through patent bioactivity data.
    Magariños MP; Gaulton A; Félix E; Kiziloren T; Arcila R; Oprea TI; Leach AR
    PeerJ; 2023; 11():e15153. PubMed ID: 37151295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: in silico drug design and medicinal chemistry).
    Singla RK
    Curr Top Med Chem; 2015; 15(11):971-2. PubMed ID: 25860175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ligand binding pockets on nuclear receptors by machine learning methods.
    Oak N; Jayaraman VK
    Protein Pept Lett; 2014; 21(8):808-14. PubMed ID: 23855664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family.
    Cases M; García-Serna R; Hettne K; Weeber M; van der Lei J; Boyer S; Mestres J
    Curr Top Med Chem; 2005; 5(8):763-72. PubMed ID: 16101416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.